Merger

Edge Focus leverages proprietary AI to secure over $100M in consumer loan deals, highlighting deep institutional demand for tech-vetted asset-backed securities.

After regaining Nasdaq compliance, Incannex Healthcare is leveraging its $75M war chest to advance novel treatments for sleep apnea and anxiety.

Facing financial headwinds, Lulus is betting big on wholesale. Can new deals with Amazon and Victoria's Secret secure its future in fashion?

Hyundai Motor Group and NVIDIA are expanding their partnership, aiming to dominate the future of autonomous vehicles with a data-driven, two-pronged strategy.

The abrdn Global Infrastructure Income Fund wants to remove its 2035 termination date, offering shareholders lower fees in exchange for a perpetual structure.

Shareholders approve a complex merger creating a larger, more diversified BDC, sweetened with special distributions and fee waivers for investors.

Private firm Top Aces will lead Argentina’s transition to F-16s, a key step in a major air force modernization with deep geopolitical implications.

Jet.AI and its partner advance their massive Canadian data center projects, securing natural gas and renewable energy to fuel the future of artificial intelligence.

The firm posted a massive $66M profit, but a $77M non-cash gain and a move to OTC markets urge investors to look beyond the impressive headlines.

The carbon firm's $5.9M debt cut sent its stock soaring, but a short cash runway and a major merger loom as critical tests for its future.

With a new CEO and private equity backing, meQuilibrium is betting its AI platform can solve the billion-dollar burnout and mental health crisis.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

Wiz, SailPoint, and Vanta are adopting Sweep’s agentic AI to manage and audit legacy Salesforce environments, signaling a major shift in enterprise governance.

With over half a billion in new capital, the growth equity firm doubles down on its data-driven playbook for scaling the next generation of consumer brands.

Amid rising costs and AI anxiety, a new poll shows consumers trust value and consistency, boosting Costco to #1 while Target and tech giants falter.

As automation demand soars, ATS Corp. will meet investors to outline its strategy for navigating market shifts and capitalizing on life sciences growth.

Easterly Asset Management's deal to absorb Olstein's funds marks a key industry consolidation, promising lower fees and a unified value investing powerhouse.

Services-focused PE firm Uplift Investors hires Evan Trent to lead a new M&A and Integration Center, signaling a deep focus on post-deal execution.

A new report shows automakers are racing to innovate with AI, but a troubling decline in safety standard adherence puts the industry at a critical crossroads.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.